Thus, in the absence of tumour VDR signalling, many of the reported immunological effects of vitamin D3 might oppose the immunological attack on the tumour in the elimination phase including downregulation of IFNG production and downregulated activity of NK cells, γδT cells, Th‐1 cells, CTLs and Th‐17 cells. The gene discussed is VDR; the disease is neoplasm.